CLL Coverage from Every Angle

In Memoriam: Remembering Hematologist Steve E. Coutre, MD

By: JNCCN 360 Staff
Posted: Wednesday, January 12, 2022

Steve E. Coutre, MD, Professor of Hematology at the Stanford School of Medicine, died on November 9, 2021, in Palo Alto, California, from complications of chronic lymphocytic leukemia (CLL) and COVID-19. He was 62.

Director of Stanford Health Care’s Hematology Clinic, Dr. Coutre also served on the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology panel for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. In addition to treating patients at the Stanford Cancer Institute, Dr. Coutre conducted clinical trials at the Hematology Malignancies Program. In fact, he served as the principal investigator of a National Cancer Institute–funded phase III trial on a novel anticancer drug in older patients with CLL.

“Steve was a leader in the Stanford Medicine community and around the world in driving comprehensive and cooperative research to develop groundbreaking treatments for patients with hematological disorders and malignancies,” said Lloyd Minor, MD, Dean of the Stanford University School of Medicine. “He will be remembered for his compassion with patients and for his intelligence and humility as a colleague, collaborator, and mentor to the next generation of physician-scientists.”

The Dr. Steven E. Coutre Research and Education Fund has been established in Dr. Coutre’s honor to further his passion and legacy of research in hematology and to support the continued education of hematology fellows. To make a gift online, visit

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.